Smartway Pharmaceuticals Limited
Smartway Pharmaceuticals Limited, headquartered in Great Britain, is a prominent player in the pharmaceutical industry, specialising in the development and distribution of innovative healthcare solutions. Founded in the early 2000s, the company has achieved significant milestones, establishing a strong presence in both domestic and international markets. With a focus on prescription medications and over-the-counter products, Smartway Pharmaceuticals is renowned for its commitment to quality and efficacy. Their unique formulations and patient-centric approach set them apart in a competitive landscape. The company has garnered recognition for its robust research and development initiatives, positioning itself as a trusted name in healthcare. Smartway Pharmaceuticals Limited continues to expand its portfolio, striving to meet the evolving needs of patients and healthcare providers alike, while maintaining a strong market position through strategic partnerships and a dedication to innovation.
DitchCarbon Score
How does Smartway Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Smartway Pharmaceuticals Limited's score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Smartway Pharmaceuticals Limited's reported carbon emissions
Smartway Pharmaceuticals Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Smartway Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust climate strategies and disclose emissions data to align with global sustainability goals. Without specific emissions figures or reduction initiatives, Smartway Pharmaceuticals Limited may face challenges in demonstrating its commitment to environmental responsibility and climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Smartway Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
